Skip to main content

Table 4 Perceived importance of MOT for diagnosis, prognosis, treatment now and in 5 years

From: Postal survey of physicians and laboratories: Practices and perceptions of molecular oncology testing

 

Physicians No. (%)

Testing labs No. (%)

Referring labs No. (%)

p-value

 

Fairly important

Very important

Fairly important

Very Important

Fairly important

Very important

Very important

Treatment now

92/271 (33.9)

85/271 (31.4)

4/17 (23.5)

12/17 (70.6)

14/39 (35.9)

15/39 (38.5)

0.004

Prognosis now

127/273 (46.5)

78/273 (28.6)

5/17 (29.4)

11/17 (64.7)

13/39 (33.3)

16/39 (41.0)

0.004

Diagnosis now

98/272 (36.0)

67/272 (24.6)

3/17 (17.6)

13/17 (76.5)

13/39 (33.3)

12/39 (30.8)

< 0.001

Treatment in 5 yrs

79/270 (29.3)

141/270 (52.2)

1/16 (6.2)

15/16 (93.8)

14/39 (35.9)

18/39 (46.2)

0.003

Prognosis in 5 yrs

95/274 (34.7)

140/274 (51.1)

1/16 (6.2)

15/16 (93.8)

16/39 (41.0)

18/39 (46.2)

0.003

Diagnosis in 5 yrs

97/272 (35.7)

109/272 (40.1)

2/16 (12.5)

14/16 (87.5)

16/39 (41.0)

15/39 (38.5)

0.001